241 related articles for article (PubMed ID: 17663505)
1. E-cadherin and beta-catenin expression in Epstein-Barr virus-associated gastric carcinoma and their prognostic significance.
Koriyama C; Akiba S; Itoh T; Sueyoshi K; Minakami Y; Corvalan A; Yonezawa S; Eizuru Y
World J Gastroenterol; 2007 Aug; 13(29):3925-31. PubMed ID: 17663505
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus, beta-catenin, and E-cadherin in gastric carcinomas.
Jung IM; Chung JK; Kim YA; Kim JE; Heo SC; Ahn YJ; Hwang KT; Kim BG; Lee KL; Kim CW; Kim WH; Chang MS
J Korean Med Sci; 2007 Oct; 22(5):855-61. PubMed ID: 17982235
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Epstein-Barr virus involvement in gastric carcinoma in Japan.
Koriyama C; Akiba S; Itoh T; Kijima Y; Sueyoshi K; Corvalan A; Herrera-Goepfer R; Eizuru Y
Int J Mol Med; 2002 Nov; 10(5):635-9. PubMed ID: 12373307
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-associated gastric carcinoma in Cali, Colombia.
Carrascal E; Koriyama C; Akiba S; Tamayo O; Itoh T; Eizuru Y; Garcia F; Sera M; Carrasquilla G; Piazuelo MB; Florez L; Bravo JC
Oncol Rep; 2003; 10(4):1059-62. PubMed ID: 12792770
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.
Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS
Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations.
Wu MS; Shun CT; Wu CC; Hsu TY; Lin MT; Chang MC; Wang HP; Lin JT
Gastroenterology; 2000 Jun; 118(6):1031-8. PubMed ID: 10833477
[TBL] [Abstract][Full Text] [Related]
7. Loss of p16/CDKN2A protein in Epstein-Barr virus-associated gastric carcinoma.
Koriyama C; Kitajima S; Nomoto M; Sueyoshi K; Itoh T; Eizuru Y; Yonezawa S; Akiba S
Oncology; 2004; 67(1):81-7. PubMed ID: 15459500
[TBL] [Abstract][Full Text] [Related]
8. Histology-specific gender, age and tumor-location distributions of Epstein-Barr virus-associated gastric carcinoma in Japan.
Koriyama C; Akiba S; Corvalan A; Carrascal E; Itoh T; Herrera-Goepfert R; Eizuru Y; Tokunaga M
Oncol Rep; 2004 Sep; 12(3):543-7. PubMed ID: 15289835
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated gastric carcinoma among patients with pernicious anemia.
Boysen T; Friborg J; Stribolt K; Hamilton-Dutoit S; Goertz S; Wohlfahrt J; Melbye M
Int J Cancer; 2011 Dec; 129(11):2756-60. PubMed ID: 21225628
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus associated gastric carcinoma: epidemiological and clinicopathological features.
Akiba S; Koriyama C; Herrera-Goepfert R; Eizuru Y
Cancer Sci; 2008 Feb; 99(2):195-201. PubMed ID: 18271915
[TBL] [Abstract][Full Text] [Related]
11. Cell-cycle regulators, bcl-2 and NF-kappaB in Epstein-Barr virus-positive gastric carcinomas.
Chang MS; Lee HS; Jung EJ; Kim CW; Lee BL; Kim WH
Int J Oncol; 2005 Nov; 27(5):1265-72. PubMed ID: 16211221
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of apoptosis related proteins and nitric oxide synthases in Epstein Barr associated gastric carcinomas.
Begnami MD; Montagnini AL; Vettore AL; Nonogaki S; Brait M; Simoes-Sato AY; Seixas AQ; Soares FA
World J Gastroenterol; 2006 Aug; 12(31):4959-65. PubMed ID: 16937490
[TBL] [Abstract][Full Text] [Related]
13. The Epstein-Barr virus-associated gastric carcinoma in Southern and Northern China.
Hao Z; Koriyama C; Akiba S; Li J; Luo X; Itoh T; Eizuru Y; Zou J
Oncol Rep; 2002; 9(6):1293-8. PubMed ID: 12375037
[TBL] [Abstract][Full Text] [Related]
14. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.
Sudo M; Chong JM; Sakuma K; Ushiku T; Uozaki H; Nagai H; Funata N; Matsumoto Y; Fukayama M
Int J Cancer; 2004 Mar; 109(2):194-9. PubMed ID: 14750169
[TBL] [Abstract][Full Text] [Related]
15. Clinical and pathological characterization of Epstein-Barr virus-associated gastric carcinomas in Portugal.
Ribeiro J; Oliveira A; Malta M; Oliveira C; Silva F; Galaghar A; Afonso LP; Neves MC; Medeiros R; Pimentel-Nunes P; Sousa H
World J Gastroenterol; 2017 Oct; 23(40):7292-7302. PubMed ID: 29142476
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-associated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma.
Kaizaki Y; Hosokawa O; Sakurai S; Fukayama M
J Gastroenterol; 2005 Jun; 40(6):570-7. PubMed ID: 16007390
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Epstein-Barr Virus Genomes and Expression Profiles in Gastric Adenocarcinoma.
Borozan I; Zapatka M; Frappier L; Ferretti V
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093097
[TBL] [Abstract][Full Text] [Related]
19. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma.
Kang GH; Lee S; Kim WH; Lee HW; Kim JC; Rhyu MG; Ro JY
Am J Pathol; 2002 Mar; 160(3):787-94. PubMed ID: 11891177
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in Epstein-Barr virus-associated stage I-III gastric carcinoma: implications for a unique type of carcinogenesis.
Huang SC; Ng KF; Chen KH; Hsu JT; Liu KH; Yeh TS; Chen TC
Oncol Rep; 2014 Aug; 32(2):530-8. PubMed ID: 24899228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
